Serum and cerebrospinal levels of calcium and magnesium in acute versus remitted schizophrenic patients Academic Article uri icon

abstract

  • KAI\GEH E-Mail karger@karger.ch Fax+ 41 61 306 12 34 http://www. karger. ch © 1996 S.KargerAG, Basel 0302-282X/96/0334-0169$10.00/0 In order to try and overcome such inconsistencies, we studied Ca and Mg serum and CSF levels in two groups of neuroleptic drug-treated schizophrenics: acute patients, and patients in remission. The aim of the study was to explore whether Ca and Mg levels differ between the acute state of schizophrenic illness and its remission with relative control of the psychotropic drug treatment variables. Subjects and Methods This study includes 8 schizophrenic patients (mean age 42.7 ± 24; range 18-63) in the acute stage of their illness and 8 schizophrenic patients (mean age 48.3 ± 19; range 18-58) in remission. The average neuroleptic treatment (in chlorpromazine equivalents) for the acute group was 820 mg/day and 470 mg/day for the remission group. These 16 patients were all …

publication date

  • January 1, 1996